According to Apellis Pharmaceuticals's latest financial reports the company's total assets are $0.78 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.78 B | 3.75% |
2022-12-31 | $0.76 B | -13.78% |
2021-12-31 | $0.88 B | -8.2% |
2020-12-31 | $0.96 B | 146.78% |
2019-12-31 | $0.38 B | 91.24% |
2018-12-31 | $0.20 B | 11.75% |
2017-12-31 | $0.18 B | 563.91% |
2016-12-31 | $27.43 M | -28.14% |
2015-12-31 | $38.17 M | 166.86% |
2014-12-31 | $14.3 M | 175.15% |
2013-12-31 | $5.19 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | -68.05% | ๐บ๐ธ USA |